换一批Pharmacokinetics of amlodipine and olmesartan after administration of amlodipine besylate and olmesartan medoxomil in separate dosage forms and as a fixed-dose combination.
第一作者：
Shashank,Rohatagi
第一单位：
Daiichi Sankyo Pharma Development, 399 Thornall Street, Edison, NJ 08837, USA. srohatagi@dsus.com
作者：
医学主题词
青少年(Adolescent);成年人(Adult);氨氯地平(Amlodipine);血管紧张素Ⅱ1型受体拮抗剂(Angiotensin II Type 1 Receptor Blockers);生物利用度(Biological Availability);钙通道阻滞药(Calcium Channel Blockers);临床试验, Ⅰ期(主题)(Clinical Trials, Phase I as Topic);复方合剂(Drug Combinations);药物相互作用(Drug Interactions);人类(Humans);咪唑类(Imidazoles);中年人(Middle Aged);随机对照试验(主题)(Randomized Controlled Trials as Topic);四唑类(Tetrazoles);治疗等效(Therapeutic Equivalency);青年人(Young Adult)
DOI
10.1177/0091270008322176
PMID
18974285
发布时间
2015-11-19
- 浏览58
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
